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Abstract
We previously confirmed the effect of sarpogrelate hydrochloride (sarpogrelate), 
5-hydroxytryptamine (5-HT) 2A receptor antagonist on cardio-ankle vascular index 
(CAVI) as a marker of systemic arterial stiffness. After 6 months of treatment with sar-
pogrelate for 35 type 2 diabetic patients, decreased CAVI, indicating the ameliorated 
arterial stiffness, was observed. Therefore, via 5-HT2A receptor blockade, sarpogrelate 
might effect as a vasoactive agent, as well as an inhibitor of platelet aggregation. 
5-HT is a known mitogen for vascular smooth muscle cells (VSMCs). In addition, 
the pathogenic change of VSMCs such as dedifferentiation and proliferation/apopto-
sis represents one of the atherosclerotic changes. On the other hand, LR11, a mosaic 
LDL receptor family member, may involve in the invasion of VSMCs into neointimal 
thickening. We therefore investigated an in vitro study to clarify whether 5-HT was 
concerned to LR11 expression and apoptosis of human VSMCs induced by 7-ketocho-
lesterol (7KCHO), a major oxidation product of cholesterol involved in plaque desta-
bilization. Resultantly, 5-HT accelerated the proliferation of VSMCs, and this effect 
was suppressed by simultaneous addition of sarpogrelate. Sarpogrelate also attenu-
ated the 5-HT–induced LR11 mRNA expression in VSMCs. Additionally, 5-HT attenu-
ated the 7KCHO-induced apoptosis of VSMCs through caspase-dependent pathway. 
These results suggest new knowledge on the modification of human VSMCs induced 
by 5-HT.
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1. Introduction
Invasion of vascular smooth muscle cells (VSMCs) to intima takes a principle finding in the 
progression of atherosclerosis and the incidence of restenosis after vascular intervention [1–
3]. Lately, LR11, a mosaic low-density lipoprotein (LDL) receptor family member, is known 
to exist largely in VSMCs of the hyperplastic intima, but not the media and induce the inva-
sion and migration potential of intimal VSMCs, speculated to originate from medial VSMCs 
[4–6]. Meanwhile, reduced extracellular matrix, reduced number of VSMCs, thin fibrous 
cap, and extracellular oxysterol accumulation have been observed in unstable plaques [7–
9]. We have previously shown that 7-ketocholesterol (7KCHO), a major oxidation product 
of cholesterol, revealed as an apoptosis inducer on VSMCs [10, 11], and attenuated the 
migration of VSMCs [12]. These reports propose that the presence of 7KCHO may reduce 
the number of VSMCs and contribute to unstable plaque. Generally, proliferation/apoptosis 
and dedifferentiation of VSMCs in the arterial intima identify one of the pathological find-
ings observed in atherogenesis [2, 13, 14]. Meanwhile, the factors modulating proliferation/
apoptosis of VSMCs and the potential cellular mechanisms are not fully elucidated.
Serotonin (5-hydroxytryptamine, 5-HT), secretion from activated platelets, is recognized to 
be a naturally occurring vasoactive mediator involved in vascular inflammation and ath-
erogenesis [15]. 5-HT has multiple receptor subtypes [16] and induces platelet aggregation, 
vasoconstriction, and VSMC proliferation [17, 18]. In addition, the plasma level of 5-hydroxy-
indole-3-acetic acid (5-HIAA; a derivative end product of 5-HT) is relatively high in subjects 
with visceral adiposity, revealing that 5-HT is one of the potential mediators for atherogenesis 
in lifestyle diseases [19].
Sarpogrelate hydrochloride (sarpogrelate), a selective 5-HT2A receptor antagonist, is used for 
diabetic patients with chronic arterial occlusive diseases [20] and is known to suppress plate-
let aggregation, vascular endothelial dysfunction, and smooth muscle contraction mediated 
via 5-HT2A receptor [21, 22]. The restorative effects of sarpogrelate on cardiovascular dis-
turbance in experimental diabetic rats were also reported [23]. Furthermore, we investigated 
prospectively the effect of sarpogrelate on systemic arterial stiffness assessed by cardio-ankle 
vascular index (CAVI) in type 2 diabetic patients [24]. After 6 months of treatment with sar-
pogrelate for 35 Japanese type 2 diabetic patients, decreased CAVI, indicating the ameliorated 
arterial stiffness, was observed (Table 1). Sarpogrelate is known to inhibit 5-HT–induced 
vascular smooth muscle contraction and/or cell proliferation [25, 26]. Moreover, Shirai et 
al. have reported that CAVI might be affected by change in contractility of vascular smooth 
muscle [27]. Therefore, these results suggest that sarpogrelate may ameliorate arterial stiff-
ness through inhibiting vascular smooth muscle contractility. However, the effects of 5-HT on 
vascular composition are not fully understood. We hypothesized that 5-HT was concerned to 
the invasion and migration of VSMCs through the regulation of LR11, besides the apoptosis 
of VSMCs.
We confirmed the effect of 5-HT on LR11 expression in human VSMCs. Additionally, whether 
there was an interaction of 5-HT with 7KCHO in inducing VSMC apoptosis was investigated.
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2. Materials and methods
2.1. Cell cultures
VSMCs prepared from human femoral artery were cultured in growth medium of Dulbecco's 
modified Eagle's minimal essential medium supplemented with delipidated calf serum 
Baseline After 6 months p Value
N (male/female) 35 (21/14) - -
Age (y) 67.4 ± 9.1 - -
Height (cm) 159.5 ± 8.1 - -
Body weight (kg) 61.9 ± 10.1 61.9 ± 10.1 0.982
BMI (kg/m2) 23.4 ± 2.9 23.4 ± 2.9 0.966
CAVI 10.11 ± 0.92 9.87 ± 0.97 0.013
sBP (mmHg) 128 ± 11 132 ± 12 0.076
dBP (mmHg) 75 ± 8 76 ± 8 0.231
TG (mg/dl) 161 ± 234 178 ± 243 0.068
HDL-C (mg/dl) 58 ± 14 55 ± 14 0.304
LDL-C (mg/dl) 98 ± 14 104 ± 34 0.054
FPG (mg/dl) 154 ± 53 153 ± 60 0.771
HbA1c (%) 7.2 ± 1.2 7.1 ± 1.2 0.463
Medication: n (%)
Sulfonylurea 11 (31.4) - -
Biguanide 6 (17.1) - -
Alpha-glucosidase inhibitor 10 (28.6) - -
Thiazolidinedione 4 (11.4) - -
ARB/ACE-I 8 (22.9) - -
Calcium channel blocker 7 (20.0) - -
Statin 15 (42.9) - -
Fibrate 5 (14.3) - -
Data are presented as mean ± standard deviation. Paired t-test was used in comparing baseline and 6-month data. 
BMI, body mass index; CAVI, cardio-ankle vascular index; sBP, systolic blood pressure; dBP, diastolic blood pressure; 
TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; FPG, fasting 
plasma glucose; HbA1c, glycosylated hemoglobin; ARB, angiotensin receptor blocker; ACE-I, angiotensin converting 
enzyme inhibitor.
Table 1. Participant characteristics before and after 6 months of sarpogrelate treatment.
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mixture or 5–10% (v/v) heat inactivated fetal calf serum (FCS), 40-μg/mL gentamicin, and 
2-mmol/L L-glutamine, maintained at 37°C in 5% carbon dioxide.
Sarpogrelate was a gifted reagent from Mitsubishi-Tanabe Pharma Co., Osaka, Japan. 5-HT, 
7KCHO, and other reagents were generously provided by Sigma (St. Louis, Missouri).
2.2. Proliferation of VSMCs
VSMCs were plated into 12-well microtiter plates in triplicate (104 cells per well). After 72 h 
of growth, the medium was changed to Dulbecco's modified Eagle medium containing 5% 
FCS and sarpogrelate and/or 5-HT was administered. Thereafter, proliferation of VSMCs was 
evaluated by a hemocytometer during 0 and 8 days after the administration of sarpogrelate 
and/or 5-HT.
2.3. Reverse transcription polymerase chain reaction
Total RNA was isolated from VSMCs by RNeasy kit (Qiagen, Courtaboeuf, France), and com-
plementary (c) DNA was prepared by reverse transcription (RT-) polymerase chain reaction 
(PCR) kit (TaKaRa, Tokyo, Japan) as already described in the manufacturer's instructions. 
RNA concentrations were evaluated by measuring absorbance at 260 nm. Thereafter, RT-PCR 
was carried out using 1 μg of reverse transcribed total RNA. Expression of β-actin internal 
standard was adopted as housekeeping gene for quantifying RNA levels. The specific primers 
were as follows:
LR11:
sense 5′-AGGAGGGCATCCTGCAGTATTGCCAAGAAG-3′
antisense 5′-TGGCGACGGTGTGCCAGTGA-3′
β-actin:
sense 5′-CTCTTCCAGCCTTCCTTCCT-3′
antisense 5′-AGCACTGTGTTGGCGTACAG-3′
PCR was run on a Gene Amp PCR System 9700 (Applied Biosystems, Foster city, CA) for 35 
cycles both for β-actin and LR11. The terminal cycle for denaturation, annealing, and elonga-
tion was required at 94°C for 30 s, 56°C for 30 s, and 72°C for 60 s for each. The amplified prod-
ucts were electrophoresed on 1% agarose gels, stained with ethidium bromide, and visualized 
by UV irradiation. Furthermore, the images were photographed using an Olympus digital 
camera (Tokyo, Japan).
2.4. Caspase activity of VSMCs
Two methods were used in order to measure caspase activity in VSMCs. First, a luminescent 
assay for measuring caspase-3 and -7 (caspase-3/7) activities was adopted. The other was flow 
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cytometric analysis by the fluorescein-5–isothiocyanate (FITC) Active Caspase-3 Apoptosis 
Kit (BD Pharmingen, La Jolla, California). After two washes in ice-cold phosphate-buffered 
saline, VSMCs incubated in 96-well microplates were scraped off the tissue culture dish, and 
caspase activities were evaluated using the Caspase-Glo® 3/7 Assay (Promega, Wisconsin) as 
described in the manufacturer's protocol.
WST-8 cell counting kit (Dojindo Laboratories, Kumamoto, Japan) was adopted to evaluate 
bioavailability of VSMCs. When serial dilutions of VSMCs were plated into 96-well microti-
ter plates and analyzed, an absorbance response at 460 nm was observed linearly (data not 
shown). The number of VSMCs was measured using the regression equation. Caspase-3/7 
activity was corrected for mean cell number measured for each.
2.5. Apoptosis of VSMCs
VSMCs were harvested by trypsinization and kept into 5-mL fluorescence-activated 
cell  sorting (FACS) tubes in phosphate buffered saline (PBS) (pH 7.4) containing 5% FCS. 
Thereafter, samples were processed in a Becton Dickinson FACScalibur (Immunocytometry 
Systems, San Jose, California) equipped with a 15 mW, 488 nm argon laser, and filter configu-
ration. BD™ Biosciences Propidium Iodide Staining Solution was adopted to quantify DNA 
content. FITC Active Caspase-3 Apoptosis Kit (BD Pharmingen) was used to evaluate active 
caspase-3. Cell samples (20,000 cells) were analyzed on a FACSort cytometer using Cell Quest 
Pro software (BD Biosciences). The percentage of apoptotic cells in each sample was quanti-
fied by manual counting of adherent VSMCs using fluorescence microscopy.
2.6. Statistical analysis
Statistical analyses were carried out using SPSS software (version 11.5, Chicago, IL, USA). The 
data are presented as mean ± standard deviation (SD). The effects of reagents were compared 
by one-way ANOVA followed by Bonferroni multiple comparison test and values of p < 0.05 
were considered statistically significant.
3. Results
3.1. Effects of 5-HT and/or sarpogrelate on VSMC proliferation
Figure 1A proposes VSMC proliferation in the absence or presence of 5-HT for 8 days. 
Administration of 5-HT (100 μM) to VSMCs significantly increased proliferation at days 5 
and 8. The cell counts of VSMCs on day 8 after the administration of 5-HT (1, 10, or 100 μM) 
with or without sarpogrelate (10 μM) were shown in Figure 1B. The administration of 5-HT 
to VSMCs induced a dose-dependent increase in cell number and simultaneous addition of 
sarpogrelate attenuated the effect of 5-HT.
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3.2. Effects of 5-HT and/or sarpogrelate on LR11 mRNA expression in VSMCs
RT-PCR showed that LR11 mRNA expression was enhanced dose dependently by adminis-
tration of 5-HT at 1–100 μM in VSMCs. Additionally, simultaneous addition of sarpogrelate 
at 10 μM attenuated the effect of 5-HT (Figure 2).
3.3. Effects of 5-HT and/or 7KCHO on caspase activity in VSMCs
The effects of 5-HT and/or 7KCHO on caspase activity in VSMCs were examined using two 
methods. Flow cytometric analysis was carried out by VSMCs stained with FITC-conjugated 
Figure 1. Effects of serotonin (5-HT) and sarpogrelate on proliferation of vascular smooth muscle cells (VSMCs). 
(A) Changes in cell number over time. After seeding VSMCs in 12-well microplates (1 × 104/well, in triplicate) and 
culturing for 72 h, 5-HT (100 μM) was added. Cell number was counted from day 0 to day 8 after the addition of 
5-HT. Data are presented as mean ± SD of triplicate samples. *Significantly higher (p < 0.05, unpaired t-test) cell 
count compared with control. (B) Effects of 5-HT concentration and sarpogrelate on cell proliferation. After seeding 
VSMCs in 12-well microplates (1 × 104/well, in triplicate) and culturing for 72 h, 5-HT and sarpogrelate at indicated 
concentrations were added. Cell numbers were counted on day 8 after addition of 5-HT and/or sarpogrelate. Data are 
presented as mean ± SD of triplicate samples. *p < 0.05, **p < 0.01; one-way ANOVA followed by Bonferroni multiple 
comparison test.
Figure 2. Effects of serotonin (5-HT) and sarpogrelate on LR11 mRNA expression in vascular smooth muscle cells 
(VSMCs). After seeding VSMCs in 6-well microplates (6 × 104/well, in triplicate) and culturing for 72 h, 5-HT and 
sarpogrelate at indicated concentrations were added and cultured for another 72 h. Upper panel shows LR11 mRNA 
expression determined by reverse transcription PCR. Beta-actin expression shown in the lower panel was used as 
internal standard.
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antiactive caspase-3 monoclonal antibody. The histograms in Figure 3A propose the distribu-
tion of VSMCs. Administration of 5-HT to VSMCs alone caused a slight leftward shift of the 
peak from control, revealing an attenuation in active caspase-3 expression [28]. Contrastingly, 
administration of 7KCHO alone caused an enhancement in active caspase-3 expression as 
revealed by a rightward shift of the histogram, and this effect of 7KCHO was attenuated by 
simultaneous addition of 5-HT (Figure 3B).
Next, a luminescent assay was carried out in order to evaluate caspase-3/7 activities using 
the same protocol shown in the previous experiment. Administration of 5-HT alone did 
not change the caspase-3/7 activities in VSMCs. On the other hand, administration of 
7KCHO alone enhanced caspase-3/7 activity ninefold compared to the control, and this 
Figure 3. Effects of serotonin (5-HT) and/or 7-ketocholesterol (7KCHO) on caspase activity in vascular smooth muscle 
cells (VSMCs). (A and B) Caspase-3 activity assayed by antiactive caspase antibody and flow cytometry. After seeding 
VSMCs in 6-well microplates (8 × 104/well, in duplicate) and culturing for 48 h, VSMCs were incubated with no addition, 
addition of 5-HT (100 μM) alone, or addition of 5-HT (100 μM) and 7KCHO (50 μM) for another 48 h. The cells were 
maintained in Dulbecco's modified Eagle's minimal essential medium containing 10% FBS and 1% non essential amino 
acid, and incubated at 37°C, 5% CO2. Caspase-3 expression was analyzed using FITC-conjugated monoclonal anti active caspase-3 antibody followed by flow cytometry. Changes in active caspase-3 activity are shown in FL1 histograms. 
(C) Caspase-3/7 activities assayed by luminescent assay. VSMCs were seeded into 96-well microplates (1 × 105/well, in 
triplicate), and incubated with or without the addition of 5-HT (100 μM) and/or 7KCHO (50 μM) for 48 h. Luciferase 
activity was measured according to the protocol from Promega. Data are presented as mean ± SD of triplicate samples. 
*p < 0.01; one-way ANOVA followed by Bonferroni multiple comparison test.
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effect of 7KCHO was attenuated by simultaneous addition of 5-HT (Figure 3C). To sum up, 
almost same effects of 5-HT were shown in both methods for measuring caspase activity 
in VSMCs.
3.4. Effects of 5-HT and/or 7KCHO on quantitation of apoptosis in VSMCs
Apoptotic DNA fragmentation in VSMCs was evaluated by propidium iodide fluorescence to 
clarify the apoptosis-inducing effect of 7KCHO in the absence or presence of 5-HT (Figure 4). 
The apoptotic rate was elevated after administration of 7KCHO (50 μM) alone, but this effect 
of 7KCHO was suppressed by simultaneous addition of 5-HT at 100 μM.
4. Discussion
In the present study, 5-HT accelerated the proliferation of human VSMCs and this effect of 
5-HT was attenuated by simultaneous addition of sarpogrelate. Moreover, sarpogrelate also 
suppressed the 5-HT–induced enhancement of LR11 mRNA expression in VSMCs. 5-HT 
attenuated the 7KCHO-induced VSMC apoptosis through caspase-3/7–dependent pathway 
Figure 4. Effects of serotonin (5-HT) and/or 7-ketocholesterol (7KCHO) on quantitative analysis of apoptosis of vascular 
smooth muscle cells (VSMCs). After seeding VSMCs in 6-well microplates (8 × 104/well, in duplicate) and culturing for 
48 h, VSMCs were incubated with or without the addition of 5-HT (100 μM) for another 96 h. 7KCHO (50 μM) was 
added to some wells 72 h after the addition of 5-HT. Cells were stained with 50 μg/ml of propidium iodide after cell lysis 
and analyzed by flow cytometry. Apoptotic rate is the percentage of nuclei in the sub-G1 population representing DNA 
fragmentation as shown in FL2 histograms. Data are presented as mean ± SD of three independent experiments. *p < 0.01; 
one-way ANOVA followed by Bonferroni multiple comparison test.
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besides. There is so far no evidence providing the effect of 5-HT on LR11 expression and 
apoptosis in VSMCs. The present report demonstrates the effects of 5-HT on such pathogenic 
changes in VSMCs.
The mechanism by which 5-HT regulates the number of intimal VSMCs has not been fully 
clarified, so that the modulators for migration of VSMCs from the arterial media to the 
intima should be examined. Previous reports have shown that LR11 expression was largely 
involved in the differentiation of VSMCs. Furthermore, the VSMCs with a contractile phe-
notype observed in the arterial media do not express LR11, whereas the VSMCs in an active 
synthetic phenotype located in the intima highly express LR11 [29, 30]. Additionally, circu-
lating soluble form of LR11 concentrations in serum is known to correlate with the degree of 
coronary organic stenosis, carotid intima-media thickness, and pulmonary arterial hyperten-
sion [31–33]. These findings suggest that LR11 may play key role of modification in VSMCs 
during atherogenesis. Our data suggested that 5-HT enhanced the expression of LR11 mRNA 
in VSMCs, and simultaneous addition of sarpogrelate attenuated this effect of 5-HT. These 
results reveal that 5-HT may participate to neointimal thickening through stimulating not only 
proliferation, but also invasion of VSMCs accompanied by upregulation of LR11. Therefore, 
sarpogrelate may show the pleiotropic effect on vascular tissue, such as decreased systemic 
arterial stiffness, partially through down-regulation of LR11 in VSMCs. Additionally, sarpo-
grelate was recently reported to ameliorate the development of chronic hypoxic pulmonary 
hypertension through the occurrence of increased apoptosis and decreased proliferation of 
VSMCs [34]. However, we cannot definitely consider that the effect of 5-HT on VSMCs is 
absolutely malignant to human body.
Apoptosis of VSMCs located in atheroma is known to be associ ated with vulnerable plaque 
ruptures [35, 36]. In this study, luminescent assay and flow cytometric analysis revealed that 
7KCHO enhanced the caspase-3/7–dependent apoptotic pathway. In a phase of progressive 
atherosclerotic plaque formation, 7KCHO is speculated to induce the absence of VSMCs, 
which make plaque unstable leading to rupture. Meanwhile, simultaneous addition of 
5-HT suppressed 7KCHO-induced VSMC apoptosis. These findings reveal that 5-HT may 
reduce the occurrence of plaque rupture through the attenuation of 7KCHO-induced VSMC 
apoptosis.
Whether 5-HT is favorable or not for the vascular remodeling process is still controversial. In 
state of vascular injury, subsequent platelet activation accompanied by endothelial damage 
provides increasing local plasma level of 5-HT. Furthermore, 5-HT causes the proliferation, 
contraction, and migration of VSMCs through the 5-HT2A receptor amplified by various 
intracellular signaling pathways [37–39]. Thus, 5-HT plays the basic principle of vascular 
repair, which spreads to neointimal thickening and decrease of peripheral blood flow. Note 
that the administration of 5-HT to VSMCs resulted in the enhancement of potential for cell 
migration caused by up-regulation of LR11 in the present study. Moreover, the suppressive 
effect of 5-HT on VSMC apoptosis might concern to the suppression of vulnerability in ath-
eromatous plaque caused by 7KCHO. These effects of 5-HT can be protective for vascular 
composition.
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It is still controversial whether modification of VSMCs along with upregulation of LR11 
directly concern to the attenuation in apoptosis-inducing effect of 7KCHO. Further eluci-
dation about the causal relationship of LR11 expression with VSMC apoptosis should be 
examined.
Resultantly, 5-HT accelerated the proliferation of VSMCs, and this effect was suppressed by 
simultaneous addition of sarpogrelate. Sarpogrelate also attenuated the 5-HT–induced LR11 
mRNA expression in VSMCs. Additionally, 5-HT attenuated the 7KCHO-induced apoptosis 
of VSMCs through caspase-dependent pathway. These results suggest new knowledge on the 
modification of human VSMCs induced by 5-HT.
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